Emcure Pharmaceuticals to acquire remaining stake in its Subsidiary Zuventus Healthcare Ltd

Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) today announced that its Board of Directors has approved to enter into agreement with minority shareholders of Zuventus Healthcare Ltd., one of its subsidiaries, to acquire their shareholding. Following the completion of this transaction, Zuventus will become a wholly owned subsidiary of Emcure. The transaction is expected to close in Q2 FY 2026.

The domestic market remains a strategic priority for Emcure. This transaction will enable full financial consolidation of Zuventus and drive long-term value creation for Emcure, through alignment across its domestic business and unlock synergies.

Shares of Emcure Pharmaceuticals Limited was last trading in BSE at Rs. 1312.35 as compared to the previous close of Rs. 1324.30. The total number of shares traded during the day was 5895 in over 529 trades.

The stock hit an intraday high of Rs. 1355.95 and intraday low of 1291.35. The net turnover during the day was Rs. 7736090.00.

Source : Equity Bulls

Keywords

EmcurePharmaceuticals INE168P01015 StakeAcquisition StakeIncrease ZuventureHealthcare